Navigation Links
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/16/2010

reclinical work and/or clinical activities to support regulatory filings, including prior to the filing or the approval of an NDA for ANX-530 and/or ANX-514, which activities may increase the cost and timeline to NDA filling or approval and negatively impact our ability to raise additional capital; the potential that changes made in transferring the manufacturing process for ANX-530 and ANX-514 may result in a lack of comparability between the commercial product and the material used in clinical trials, and that FDA may require ADVENTRX to perform additional non-clinical or clinical studies; the risk the FDA will determine that ANX-530 and Navelbine® and/or ANX-514 and Taxotere® are not bioequivalent, including as a result of performing pharmacokinetic equivalence analysis based on a patient population other than the population on which ADVENTRX based its analysis or determining that increased docetaxel blood-levels during and immediately following infusion are clinically relevant; the risk of investigator bias in reporting adverse events as a result of the open-label nature of the ANX-530 bioequivalence study; difficulties or delays in manufacturing, obtaining regulatory approval for and marketing ANX-530 and ANX-514, including validating commercial manufacturing processes and manufacturers, as well as suppliers, and the potential for automatic injunctions regarding FDA approval of ANX-514; ADVENTRX's reliance on the performance of third parties to assist in the conduct of its bioequivalence trials, regulatory submissions, CMC activities and other important aspects of the ANX-530 and ANX-514 development programs, including on-going stability studies for ANX-530 and analysis of the ANX-514 bioequivalence trial data, and that such third parties may fail to perform as expected; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission.  ADVENTRX's public filings w
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. ADVENTRX Receives Brand Name Acceptance for ANX-530
2. ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
3. ADVENTRX Announces Management Promotions
4. ADVENTRX Appoints Icahn Representative to Board of Directors
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
7. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Eli Lilly and Company ... its previously announced cash tender offer for up to $1.6 ... securities. Holders of notes who tendered, and did ... New York City time, on May ... for purchase by Lilly, are eligible to receive the total ...
(Date:5/28/2015)... , May 28, 2015  Maetrics ( http://maetrics.com ), ... sciences sector, wrapped up a successful conference, "The cost ... Technology industry," today in Zurich . ... ) and its Switzerland -based team, ... the Medical Technology field to an exclusive local audience. ...
(Date:5/28/2015)... This report analyzes the worldwide markets for Intraocular ... Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. The report ... , Japan , Europe ... America , and Rest of World. Annual estimates and ... a seven-year historic analysis is provided for these markets. Market ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26
... ResMed Inc. (NYSE: RMD ) today ... has resigned his position as Chief Executive Officer and ...  The board has appointed Dr. Peter C. Farrell, ResMed,s ... Executive Officer and President, effective January 28, 2011.  Dr. ...
... (NYSE: DGX ) today announced the pricing of ... Quest Diagnostics common stock held by its largest stockholder, SB ... a price to the public of $56.25.   ... in the offering and will not receive any of the ...
Cached Medicine Technology:ResMed Inc. Announces Management Changes 2ResMed Inc. Announces Management Changes 3Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder 2
(Date:5/29/2015)... An organizational consultant and part-time college ... his memory and may be suffering from early dementia. ... professional life and in his uncertain relationship with his ... career working with corporate and government movers and shakers ... family members around him are being diagnosed with Alzheimer’s, ...
(Date:5/29/2015)... DISC, a method of behavioral analysis that ... used by companies to improve hiring practices, streamline training, ... an out-of-the-box practice, has now become an integral part ... Society for Human Resource Management found that over 70% ... be an essential part of the hiring process, and ...
(Date:5/29/2015)... 2015 Wimbledon Health Partners, the leading ... echocardiogram and NCV testing, is proud to announce ... for EKG interpretation of athletes. , Sudden ... during athletic activity. New findings presented in February have ... improve cardiac safety in athletes. Physiologic adaptations in athletic ...
(Date:5/29/2015)... 2015 The 3D Certificate program is ... the business, finance, and engineering aspects of evaluating 3D ... technology, an expansion in their existing 3D investment, or ... of 3D technology in manufacturing in various fields, will ... will include courses that cover the following topics: state ...
(Date:5/29/2015)... 2015 Pastor and Overseer, Yisrayl Hawkins, at ... how the name of The Creator was removed and replaced, ... writes that for many years the Name of the Creator ... are actually not the original writings. He adds that there ... the Creator to cause deception and intentionally mislead people. , ...
Breaking Medicine News(10 mins):Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 2Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 3Health News:In New Post This Week, Yisrayl Hawkins Praises Religious Leaders For Confessing Yahweh Is The Name Of The Creator 2
... BRANFORD, Conn., Nov. 5 CuraGen Corporation,(Nasdaq: CRGN ... that Dr. Timothy M. Shannon, President and Chief,Executive Officer, ... Renshaw,Annual Global Investment Conference on Wednesday, November 12, 2008, ... at the New York Palace,Hotel in New York, NY., ...
... of smaller companies is often dependent on their ability to ... Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical ... on critical aspects of deal-making, including valuations and royalty rate ... ...
... Have Been Identified and More Are Still to be ... Resource Detectives,program, developed by the Multiple Sclerosis Association of ... in giving,back to the community but unable to do ... first year the Resource Detectives program,energized a group of ...
... Global Safe Sex Campaigning, LONDON, Nov. 5 MTV,s ... Ed and Mervin are the latest in a,long line of ... tenth anniversary. A series of specially-created shorts have,been commissioned by ... Chris Waitt and Henry Trotter -- and will premiere during ...
... Interservice/Industry Training, Simulation and Education Conference (I/ITSEC) ... huge Orange County Convention Center in Orlando. Occupying ... exhibition of modeling and simulation technology ever. ... December 1-4, 2008 at the Orange County Convention ...
... a lot of heat for not being more child and animal safe. ... implement several features designed to prevent dangerous injuries. , ... Kaysville, UT ... online for over 12 years and has seen many trends in ...
Cached Medicine News:Health News:Determining Valuations in Challenging Times 2Health News:Determining Valuations in Challenging Times 3Health News:Determining Valuations in Challenging Times 4Health News:Multiple Sclerosis Association of America's Resource Detectives(SM) Program Marks One Year Anniversary 2Health News:Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 2Health News:Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 3Health News:Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 4Health News:Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 5Health News:Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 6Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 2Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 3Health News:Office Zone Announces New Line of 'Safer' Paper Shredders 2
The Duran Flexible Annuloplasty System encompasses both performance and practicality....
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
Medicine Products: